An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients
Clinical trial NCT01518309 · COMPLETED
Trial details
- NCT number
- NCT01518309
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-17
- Primary completion
- 2013-05-02
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.